Form 4: Encompass Health CEO Mark Tarr Reports Stock Disposals for Tax Obligations
SEC Form 4 Filing
Encompass Health's CEO, Mark Tarr, disposed of shares to cover tax obligations related to the vesting of restricted stock.
Summary
- Mark J. Tarr, President & CEO of Encompass Health Corp, reported changes in beneficial ownership.
- On February 24, 2025, Tarr disposed of 2,488 shares of Encompass Health Common Stock at a price of $97.53 per share to cover tax obligations.
- On February 25, 2025, Tarr disposed of 2,896 shares of Encompass Health Common Stock at a price of $100.63 per share to cover tax obligations.
- Following these transactions, Tarr beneficially owns 529,257 shares of Encompass Health Common Stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing reflects routine stock disposals for tax purposes, which is a normal part of executive compensation.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The stock disposal may have a minor impact on shareholders due to the increased supply of shares, but it is unlikely to be significant given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 02/24/2025 | Disposal of 2,488 shares of Encompass Health Common Stock at $97.53 per share. |
| 02/25/2025 | Disposal of 2,896 shares of Encompass Health Common Stock at $100.63 per share. |
| 02/26/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.